3136 results for «2886»
3136 results
How to solve tricky coronary complications
16 May 2024 – From EuroPCR 2024
From balloon rupture during double-kissing crush stenting to a successful bailout for delayed coronary obstruction post-TAVI, and an unforeseen complication after chimney stenting in a high-risk patient, the session covers it all. Learn about the nuclear mushroom phenomenon during PCI in a calcified LAD, strategies for...
Percutaneous tricuspid treatment in challenging anatomies
16 May 2024 – From EuroPCR 2024
Watch this session on percutaneous tricuspid treatment to explore key cases, including managing tricuspid valve-in-valve implantation in a patient with a giant right atrium, transcatheter edge-to-edge repair post-Mustard procedure, and tricuspid replacement in a challenging extreme anatomy case. You'll also learn about cross-caval treatment for torrential...
Acute coronary syndrome caused by coronary aneurysms
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary artery aneurysms. Participants will learn about the diagnosis, management, and treatment strategies for these rare and complex cases, including the use of imaging and interventional techniques to address the underlying pathology.
CTO within a bifurcation
16 May 2024 – From EuroPCR 2024
This session will present various cases of chronic total occlusions (CTOs) within a bifurcation. Participants will learn about the challenges, diagnostic techniques, and treatment strategies for these complex cases, including the use of IVUS, CT angiography, and the hybrid algorithm for successful CTO interventions.
Leading innovation for patients with valvular heart disease
24 Nov 2024 – From PCR London Valves 2024
Discover the newest advancements in transcatheter heart valves and their role in modern lifetime management of valvular heart disease. Review the latest clinical outcomes demonstrating improved patient care and explore how a diverse device portfolio addresses a wide range of valve anatomies.
Rendez-vous with Myval THV series and Landmark RCT subset analysis
24 Nov 2024 – From PCR London Valves 2024
Discover this interactive session during which the audience learns about and discusses the novel Myval THV Series, a series of valves featuring intermediate and XL sizes. They also discuss the results of the pivotal LANDMARK randomized controlled trial and its relevance in clinical practice.
Optimisation of your valve implantation to ensure lifelong outcomes using a novel self-expanding valve
24 Nov 2024 – From PCR London Valves 2024
Gain insights into the importance of valve optimization post-implantation to secure acute and long-term outcomes. In this session, you will discover the new features and benefits of the ACURATE Prime platform illustrated by a recorded case, and compare how different TAVI platforms perform when treating larger...
Innovation never stops: Cardiovalve in action!
24 Nov 2024 – From PCR London Valves 2024
Join us as we explore the latest advancements in transcatheter tricuspid valve replacement technologies. This session develops the anatomical and imaging challenges associated with this rapidly developing clinical field and provides an update on the Cardiovalve tricuspid clinical program, illustrated by a recorded case.
RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation
25 Nov 2024 – From PCR London Valves 2024
Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...
A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system
25 Nov 2024 – From PCR London Valves 2024
Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
The many faces of complex TAVI
25 Nov 2024 – From PCR London Valves 2024
Learn how to navigate challenging cases illustrating the complexities of TAVI procedures and the importance of device selection and implantation technique. Discover strategies for tackling issues like bicuspid aortic stenosis, difficult access, and complex anatomies.
TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.
Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore the latest trial results and insights on treating bicuspid aortic stenosis with self-expanding valves. Learn key tips for optimal outcomes, including the importance of supra-annular assessment, appropriate sizing, and techniques to prevent underexpansion. Discover the VitaFlow specifications and clinical data, including...
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease
26 Nov 2024 – From PCR London Valves 2024
Explore this session to learn about the unmet needs in aortic regurgitation (AR) and the performance of dedicated TAVI devices for AR. Discover why new thresholds for severe AR are necessary, and how traditional methods may underestimate its severity. Gain insights into the TRILOGY THV system,...
From index procedure to re-valving with a novel self-expanding valve
25 Nov 2024 – From PCR London Valves 2024
Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning
26 Nov 2024 – From PCR London Valves 2024
Explore the differentiating features of the PASCAL Precision system for the treatment of patients with mitral regurgitation through simulation and case-based learning.
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
